Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell function

Journal of Immunotherapy

Volumn 23, Issue 3, 2000, Pages 311-320

  Bedrosian, Isabelle ^a   Roros, James G ^a   Xu, Shuwen ^a   Nguyen, Hung Q ^a   Engels, Friederike ^a   Faries, Mark B ^a   Koski, Gary K ^b   Cohen, Peter A ^b   Czerniecki, Brian J ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Calcineurin; Calcium ionophore; Cytokines; Immature dendritic cells; Melanoma peptides

Indexed keywords

ANTIGEN; CALCINEURIN; CALCIUM IONOPHORE; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CYCLOSPORIN A; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL FUNCTION; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKAPHERESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW CELLS; CALCIUM; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOSPORINE; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-12; INTERLEUKIN-2; IONOPHORES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PINOCYTOSIS;

EID: 0034079336     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200005000-00004     Document Type: Article

References (32)

1. Croft M, Bradley M, Swain S. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675-85.
2. Crowley M, Inaba K, Steinman R. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 1990;172:383-6.
3. Mayordomo J, Zorina T, Storkus W, et al. Bone marrow derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Medicine 1995; 1:1297-1302.
4. Ashley DM, Faiola B, Nair S, et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997;186:1177-82.
5. Coveney E, Wheatley G, Lyerly H. Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer. Surgery 1997;122:228-34.
6. Hsu F, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine 1996;2:52-8.
7. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Medicine 1998;4:328-32.
8. Salgaller M, Tjoa B, Lodge P, et al. Dendritic cell based immunotherapy of prostate cancer. Crit Rev Immunol 1998;18:109-19.
9. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18.
10. Czerniecki B, Carter C, Rivoltini L, et al. Calcium ionophore treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 1997; 159:3823-37.
11. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
12. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
13. + dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-92.
14. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
15. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539-43.
16. Rosenberg S, Mule J, Speiss P, Reichert C, Schwarz S. Regression of established pulmonary metastasis and subcutaneous tumor by the systemic administration of high-dose recombinant interleukin-2. J Exp Med 1985;161:1169-88.
17. Rosenberg S, Yang J, Topalian S, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cacinoma using high dose bolus interleukin-2. JAMA 1994;271:907-13.
18. Noguchi Y, Richards E, Chen Y, Old L. Influence of interleukin-12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 1995;92:2219-23.
19. Zitvogel L, Couderc B, Mayordomo JI, et al. IL-12 Engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann N Y Acad Sci 1996;795:284-93.
20. Rivoltini L, Kawakami Y, Sakaguchi K, et al. Induction ot tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol 1995;154:2257-65.
21. Romani N, Koide S, Crowley M, et al. Presentation ot exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989;169:1169-78.
22. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr Opin Immunol 1996;8:348-54.
23. Larsson M, Majeed M, Ernst J, et al. Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology 1997;92:501-11.
24. Koski GK, Schwartz GN, Weng DE, et al. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J Immunol 1999;163:82-92.
25. + peripheral blood monocytes. J Immunol 1996;157:3850-9.
26. Peters J, Xu H, Ruppert J, et al. Signals required for differentiating dendritic cells from human monocytes in vitro. Adv Exp Med Biol 1993;329:275-80.
27. Kuhn U, Brand P, Willemsen J, et al. Induction of tyrosine phosphorylation in human MHC class II-positive antigen presenting cells by stimulation with contact sensitizers. J Immunol 1998;160: 667-73.
28. + hematopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J Immunol 1998;160:3689-97.
29. + T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
30. + T lymphocytes in the P815 tumor system in vitro. J Immunol 1996; 156:465-72.
31. Bellone M, Iezzi G, Manfredi A, et al. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen presenting cells. Eur J Immunol 1994;24:2691-98.
32. + cytolytic T lymphocytes. J Exp Med 1996;183:791-800.